Cell viability of LN-18 GBM neurosphere cells was strongly reduced by both LY294002 as a dual PI3K/PIM1 inhibitor and the selective PIM1 antagonist TCS PIM1-1, whereas temozolomide was ineffective. The gene discussed is PIM1; the disease is glioblastoma.